DentalCare Logo

Therapeutic Mouthrinsing: An Effective Component to Oral Hygiene

Course Number: 317

References / Additional Resources

  1. More Than A Quarter of U.S. Adults Are Dishonest with Dentists About How Often They Floss Their Teeth. American Academy of Periodontology. Accessed April 11, 2019.

  2. American Dental Association (ADA) Division of Science. For the patient. Keeping your gums healthy. J Am Dent Assoc. 2015 Apr;146(4):A46. doi: 10.1016/j.adaj.2015.01.021.

  3. Guynup S. Our Mouths, Ourselves. Sci Am 2006;Supplemental Issue: 3-5. Accessed April 11, 2019.

  4. Hughes P. Aging, Systemic Disease and Oral Health: Implications for Women Worldwide (Part I). Accessed April 11, 2019.

  5. Ross PE. Invaders and the body's defenses. Sci Am 2006;Supplemental Issue:6-11. Accessed April 11, 2019.

  6. Paraskevas S. Randomized controlled clinical trials on agents used for chemical plaque control. Int J Dent Hyg. 2005 Nov;3(4):162-78. doi: 10.1111/j.1601-5037.2005.00145.x

  7. Food and Drug Administration, HHS. Oral health care drug products for over-the-counter human use antigingivitis/antiplaque drug products; establishment of a monograph; proposed rules. Fed Regist. 2003 May 29;68(103):32232-87. Accessed April 11, 2019.

  8. Eldridge KR, Finnie SF, Stephens JA, et al. Efficacy of an alcohol-free chlorhexidine mouthrinse as an antimicrobial agent. J Prosthet Dent. 1998 Dec;80(6):685-90.

  9. Peridex prescribing information. Accessed April 11, 2019.

  10. Stookey GK, Beiswanger B, Mau M, et al. A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses. Am J Dent. 2005 Jul;18 Spec No:24A-28A.

  11. Quirynen M, Soers C, Desnyder M, et al. A 0.05% cetyl pyridinium chloride/0.05% chlorhexidine mouth rinse during maintenance phase after initial periodontal therapy. J Clin Periodontol. 2005 Apr;32(4):390-400. doi: 10.1111/j.1600-051X.2005.00685.x

  12. Lorenz K, Bruhn G, Heumann C, et al. Effect of two new chlorhexidine mouthrinses on the development of dental plaque, gingivitis, and discolouration. A randomized, investigator-blind, placebo-controlled, 3-week experimental gingivitis study. J Clin Periodontol. 2006 Aug;33(8):561-7. doi: 10.1111/j.1600-051X.2006.00946.x

  13. Hase JC, Attström R, Edwardsson S, et al. 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. J Clin Periodontol. 1998 Sep;25(9):746-53.

  14. Lang NP, Hase JC, Grassi M, et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Dis. 1998 Jun;4(2):105-13.

  15. Ciancio SG. Antiseptics and antibiotics as chemotherapeutic agents for periodontitis management. Compend Contin Educ Dent. 2000 Jan;21(1):59-62, 64, 66 passim; quiz 78.

  16. Scheie AA. Modes of action of currently known chemical antiplaque agents other than chlorhexidine. J Dent Res. 1989;68 (Spec Iss):1609-1616. Accessed April 11, 2019.

  17. White DJ. An alcohol-free therapeutic mouthrinse with cetylpyridinium chloride (CPC)--the latest advance in preventive care: Crest Pro-Health Rinse. Am J Dent. 2005 Jul;18 Spec No:3A-8A.

  18. Jenkins S, Addy M, Wade W, et al. The magnitude and duration of the effects of some mouthrinse products on salivary bacterial counts. J Clin Periodontol. 1994 Jul;21(6):397-401.

  19. Hunter-Rinderle SJ, Bacca LA, McCaughlin KT, et al. Evaluation of Cetylpyridinium Chloride-Containing Mouthwashes Using In Vitro Disk Retention and Ex Vivo Plaque Glycolysis Methods. J Clin Dent. 1997;8:107-113

  20. Mankodi S, Bauroth K, Witt JJ, et al. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque. Am J Dent. 2005 Jul;18 Spec No:9A-14A.

  21. Allen DR, Davies R, Bradshaw B, et al. Efficacy of a mouthrinse containing 0.05% cetylpyridinium chloride for the control of plaque and gingivitis: a 6-month clinical study in adults. Compend Contin Educ Dent. 1998;19(2 Suppl):20-6.

  22. Witt JJ, Walters P, Bsoul S, et al. Comparative clinical trial of two antigingivitis mouthrinses. Am J Dent. 2005 Jul;18 Spec No:15A-17A.

  23. Albert-Kiszely A, Pjetursson BE, Salvi GE, et al. Comparison of the effects of cetylpyridinium chloride with an essential oil mouth rinse on dental plaque and gingivitis - a six-month randomized controlled clinical trial. J Clin Periodontol. 2007 Aug;34(8):658-67. doi: 10.1111/j.1600-051X.2007.01103.x

  24. Blenman TV, Morrison KL, Tsau GJ, et al. Practice implications with an alcohol-free, 0.07% cetylpyridinium chloride mouthrinse. Am J Dent. 2005 Jul;18 Spec No:29A-34A.

  25. Busscher HJ. Cetylpyridinium chloride rinse bioavailability assessed by plaque vitality kinetics. [287] J Dent Res (AADR/IADR) 2006;85, Abstract 691.

  26. Fine DH. Mouthrinses as adjuncts for plaque and gingivitis management. A status report for the American Journal of Dentistry. Am J Dent. 1988 Dec;1(6):259-63.

  27. Charles CH, Mostler KM, Bartels LL, et al. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol. 2004 Oct;31(10):878-84. doi: 10.1111/j.1600-051X.2004.00578.x

  28. Lang NP, Hase JC, Grassi M, et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Dis. 1998 Jun;4(2):105-13.

  29. Sharma N, Charles CH, Lynch MC, et al. Adjunctive benefit of an essential oil-containing mouthrinse in reducing plaque and gingivitis in patients who brush and floss regularly: a six-month study. J Am Dent Assoc. 2004 Apr;135(4):496-504.

  30. Bauroth K, Charles CH, Mankodi SM, et al. The efficacy of an essential oil antiseptic mouthrinse vs. dental floss in controlling interproximal gingivitis: a comparative study. J Am Dent Assoc. 2003 Mar;134(3):359-65.

  31. Sharma NC, Charles CH, Qaqish JG, et al. Comparative effectiveness of an essential oil mouthrinse and dental floss in controlling interproximal gingivitis and plaque. Am J Dent. 2002 Dec;15(6):351-5.

  32. Charles CH, Sharma NC, Galustians HJ, et al. Comparative efficacy of an antiseptic mouthrinse and an antiplaque/antigingivitis dentifrice. A six-month clinical trial. J Am Dent Assoc. 2001 May;132(5):670-5.

  33. Gerlach RW, Biesbrock AR, Bartizek RD, Terezhalmy GT. Incremental clinical plaque effects with CPC and essential oils rinses. J Dent Res 2007;86 (Spec Iss). Abstract 2501.

  34. White DJ, Kozak KM, Barker ML. Antiplaque efficacy of combined therapeutics. J Dent Res 2007;86(Spec Iss). Abstract 1072.

  35. Daniel SJ, Harfst SA. Dental Hygiene Concepts, Cases, and Competencies. St. Louis: Mosby;2004:418.

  36. ADA Division of Communications. For the dental patient. Do you have dry mouth? J Am Dent Assoc. 2002 Oct;133(10):1455.

  37. Cacchillo D, Barker GJ, Barker BF. Late effects of head and neck radiation therapy and patient/dentist compliance with recommended dental care. Spec Care Dentist. 1993 Jul-Aug;13(4):159-62.

  38. Blanco-Carrion A, Rodriguez-Nunez I, Gandara-Rey JM, et al. A new mourthrinse formulation for painful lesions of the oral mucosa [in Spanish]. Rev Eur Odontol Estamatol. 1996;3:169-172.

  39. Kotsakis GA, Lan C, Barbosa J, et al. Antimicrobial Agents Used in the Treatment of Peri-Implantitis Alter the Physicochemistry and Cytocompatibility of Titanium Surfaces. J Periodontol. 2016 Jul;87(7):809-19. doi: 10.1902/jop.2016.150684. Epub 2016 Feb 28. doi: 10.1902/jop.2016.150684

Additional Resources

No Additional Resources Available